Clin2
NCT07564479Possibly a fitRecruiting

Alpha-Lipoic Acid to Protect Kidneys During Cisplatin Cancer Treatment

Cisplatin NephrotoxicityNephrotoxicity

Treatments studied

Part of Cancer, Kidney & urinary clinical trials.

This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have been diagnosed with a solid tumor (cancer) confirmed by biopsy
  • Your doctor plans to treat you with cisplatin chemotherapy at a standard dose
  • Your kidneys are working normally (measured by creatinine and glomerular filtration rate tests)
  • You are able to take care of yourself or need minimal help (ECOG performance status 0–2)
  • You are not pregnant, not breastfeeding, and not allergic to alpha-lipoic acid

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07476443Not yet recruiting· Phase 2/Phase 3
Vitamins to protect kidneys during chemotherapy

This trial tests whether taking vitamin C and coenzyme Q10 can help protect your kidneys while you receive chemotherapy with cisplatin and gemcitabine. It may reduce the risk of kidney damage from these treatments.

Cairo, Shoubra
NCT07668141Not yet recruiting· Phase 3
Alpha lipoic acid for kidney protection during colistin treatment

This trial tests whether taking alpha lipoic acid (an antioxidant) alongside the antibiotic colistin can help protect the kidneys from damage. It may be helpful for patients who need colistin to fight a serious bacterial infection.

Giza
NCT07108777Recruiting· Phase 2
L-carnitine to protect kidneys during cisplatin chemo

This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.

Shibīn al Kawm
NCT07018622Recruiting· Phase 2
Protecting kidneys from platinum chemotherapy damage

This trial tests a way to protect your kidneys while you receive platinum-based chemotherapy (cisplatin or carboplatin) for a solid tumor. It may help reduce the risk of kidney damage so you can complete your treatment more safely.

México, Tlalpan
NCT07824843Not yet recruiting· Phase 1
GMDTC injection for kidney protection during cisplatin chemo

This trial tests an injection called GMDTC to see if it can protect the kidneys in people who already have mild kidney problems from cisplatin chemotherapy and need more cisplatin. It aims to reduce further kidney damage while continuing cancer treatment.

Guangzhou, Guangdong
NCT07598214Recruiting· Phase 4
Natural supplement to protect kidneys during platinum chemotherapy

This study tests whether a natural supplement made from citrus plant compounds (diosmin and hesperidin) can protect your kidneys from damage caused by platinum-based chemotherapy drugs. Platinum chemotherapy is effective against many cancers but can harm kidney function over time.

Banī Suwayf

Hear when a new Nephrotoxicity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.